Access Pharmaceuticals (ACCP.OB): Dawson James Security Reiterates “Speculative Buy” Rating
Access Pharmaceuticals Inc., an emerging biopharmaceutical company, is focused on developing novel nanopolymer delivery technologies and products for cancer and…